What were the results of this study?
This is a summary of the main results from this study overall. The results each
participant had might be different and are not in this summary. A full list of the
questions that the researchers wanted to answer can be found on the websites
listed at the end of this summary. When a full report of the study results is
available, it can also be found on these websites.
Researchers look at the results of many studies to decide which treatments work
best and are safest. Other studies may provide new information or different
results. Always talk to a doctor before making any treatment changes.
Did dapagliflozin help prevent the participants’ CKD from getting
worse compared to the placebo?
Yes. Overall, the researchers found that dapagliflozin helped prevent the
participants’ CKD from getting worse compared to the placebo.
To answer this question, the study doctors recorded the number of participants
who had at least 1 of the CKD-related problems below. They kept track of
whether the participants:
• had a 50.0% worsening in their kidney function
• developed ESKD
• needed dialysis treatment
• needed a kidney transplant
• died from a medical problem related to the kidneys
• died from a medical problem related to the heart
They found that during the study the percentage of participants who had these
CKD-related problems was:
• 9.2% in the dapagliflozin group. This was 197 out of 2152 participants.
• 14.5% in the placebo group. This was 312 out of 2152 participants.
7 | Clinical Study Results